Ultimately, who is a good candidate for GLP-1 will depend on the specific inclusion and exclusion criteria of each trialbut in general, those struggling with weight-related health conditions and willing to engage in medical research are strong candidates
Beginning with the November 18, 2021, release of productivity data, BLS replaced the term multifactor productivity (MFP) with total factor productivity (TFP)
The STEP 1 trial (Wilding et al., NEJM 2021) demonstrated an average 14.9% body weight reduction with semaglutide 2.4mg weekly over 68 weeks, compared to 2.4% with placebo a magnitude of effect that no prior anti-obesity medication had achieved
Individual tolerance varies considerably between different agents in this class
Your body produces additional stomach acid and digestive enzymes while waiting, which can ferment undigested carbohydrates and generate extra gas that must be released as burps